An engineered bispecific human monoclonal antibody against SARS-CoV-2.
Li Z, Li S, Zhang G, Peng W, Chang Z, Zhang X, Fan Z, Chai Y, Wang F, Zhao X, Li D, Zhang R, He Z, Zou W, Xu K, Lei W, Liu P, Hao J, Zhang J, Sun L, Wu G, Tan S, Gao GF, Gao F, Wu Y.
Li Z, et al. Among authors: li s, li d.
Nat Immunol. 2022 Mar;23(3):423-430. doi: 10.1038/s41590-022-01138-w. Epub 2022 Feb 28.
Nat Immunol. 2022.
PMID: 35228696